ZA866218B - Injectable sustained release formulation - Google Patents
Injectable sustained release formulationInfo
- Publication number
- ZA866218B ZA866218B ZA866218A ZA866218A ZA866218B ZA 866218 B ZA866218 B ZA 866218B ZA 866218 A ZA866218 A ZA 866218A ZA 866218 A ZA866218 A ZA 866218A ZA 866218 B ZA866218 B ZA 866218B
- Authority
- ZA
- South Africa
- Prior art keywords
- sustained release
- release formulation
- injectable sustained
- injectable
- formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76860585A | 1985-08-23 | 1985-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA866218B true ZA866218B (en) | 1988-03-30 |
Family
ID=25082968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA866218A ZA866218B (en) | 1985-08-23 | 1986-08-18 | Injectable sustained release formulation |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0211691A3 (xx) |
| JP (1) | JPS6251624A (xx) |
| CN (1) | CN1006197B (xx) |
| AU (1) | AU591516B2 (xx) |
| CA (1) | CA1285874C (xx) |
| DK (1) | DK396286A (xx) |
| EG (1) | EG17979A (xx) |
| HU (1) | HU195425B (xx) |
| IL (1) | IL79765A (xx) |
| NZ (1) | NZ217267A (xx) |
| PH (1) | PH25861A (xx) |
| SU (1) | SU1683493A3 (xx) |
| ZA (1) | ZA866218B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1296253C (en) * | 1986-10-20 | 1992-02-25 | Praveen Tyle | Stabilized growth hormone compositions |
| US4857506A (en) * | 1987-01-12 | 1989-08-15 | American Cyanamid Company | Sustained release growth hormone compositions for parenteral administration and their use |
| US4857505A (en) * | 1987-03-09 | 1989-08-15 | American Cyanamid Company | Sustained release compositions for parenteral administration and their use |
| GB8725427D0 (en) * | 1987-10-30 | 1987-12-02 | Lilly Industries Ltd | Somatotropin formulations |
| US5021554A (en) * | 1989-02-24 | 1991-06-04 | Eli Lilly And Company | Process for protein particle size reduction using a fluid-energy mill |
| YU87892A (sh) * | 1991-10-01 | 1995-12-04 | Eli Lilly And Company Lilly Corporate Center | Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu |
| IL103275A0 (en) * | 1991-10-01 | 1993-02-21 | Lilly Co Eli | Injectable extended release formulations and methods |
| SE9303068D0 (sv) * | 1993-09-21 | 1993-09-21 | Kabi Pharmacia Ab | New use |
| CN1062129C (zh) * | 1995-09-14 | 2001-02-21 | 徐荣祥 | 药物基质及其用途 |
| KR19990071255A (ko) | 1998-02-28 | 1999-09-15 | 성재갑 | 소마토트로핀과 비타민의 합제 조성물 |
| GB9827727D0 (en) | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| CN1827766B (zh) | 2001-06-28 | 2010-08-25 | 徐荣祥 | 体外细胞的培养方法 |
| US6972195B2 (en) | 2002-09-27 | 2005-12-06 | Rongxiang Xu | Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro |
| US6685971B2 (en) * | 2001-06-28 | 2004-02-03 | Rongxiang Xu | Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2493202A (en) * | 1946-06-07 | 1950-01-03 | Merck & Co Inc | Process of making a fluid oil-beeswax vehicle for the parenteral administration of drugs |
| BE795516A (fr) * | 1972-02-17 | 1973-08-16 | Ciba Geigy | Preparations de peptides huileuses et injectables et procede pour leur preparation |
| EP0085036A1 (en) * | 1982-01-18 | 1983-08-03 | Monsanto Company | Method for improved bovine milk production |
| US4521409A (en) * | 1983-10-03 | 1985-06-04 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance ruminant mammary development |
| ES8702440A1 (es) * | 1984-10-04 | 1986-12-16 | Monsanto Co | Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa. |
| IL79681A (en) * | 1985-08-12 | 1991-06-10 | Int Minerals & Chem Corp | Transition metal complexes of growth hormones and their prolonged release compositions |
| US4775659A (en) * | 1985-08-19 | 1988-10-04 | Eli Lilly And Company | Injectable semi-solid formulations |
-
1986
- 1986-08-18 CA CA000516146A patent/CA1285874C/en not_active Expired - Lifetime
- 1986-08-18 ZA ZA866218A patent/ZA866218B/xx unknown
- 1986-08-18 IL IL79765A patent/IL79765A/xx not_active IP Right Cessation
- 1986-08-19 NZ NZ217267A patent/NZ217267A/xx unknown
- 1986-08-19 SU SU4028010A patent/SU1683493A3/ru active
- 1986-08-20 EG EG530/86A patent/EG17979A/xx active
- 1986-08-20 CN CN86105087.8A patent/CN1006197B/zh not_active Expired
- 1986-08-20 DK DK396286A patent/DK396286A/da unknown
- 1986-08-20 PH PH34167A patent/PH25861A/en unknown
- 1986-08-20 EP EP86306454A patent/EP0211691A3/en not_active Withdrawn
- 1986-08-21 AU AU61700/86A patent/AU591516B2/en not_active Ceased
- 1986-08-21 JP JP61197004A patent/JPS6251624A/ja active Pending
- 1986-08-22 HU HU863652A patent/HU195425B/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SU1683493A3 (ru) | 1991-10-07 |
| PH25861A (en) | 1991-12-02 |
| CA1285874C (en) | 1991-07-09 |
| CN86105087A (zh) | 1987-03-04 |
| CN1006197B (zh) | 1989-12-27 |
| HU195425B (en) | 1988-05-30 |
| DK396286D0 (da) | 1986-08-20 |
| AU591516B2 (en) | 1989-12-07 |
| AU6170086A (en) | 1987-02-26 |
| NZ217267A (en) | 1989-02-24 |
| EG17979A (en) | 1992-06-30 |
| IL79765A (en) | 1992-02-16 |
| JPS6251624A (ja) | 1987-03-06 |
| EP0211691A2 (en) | 1987-02-25 |
| DK396286A (da) | 1987-02-24 |
| HUT41637A (en) | 1987-05-28 |
| EP0211691A3 (en) | 1987-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0187703A3 (en) | Sustained release preparation | |
| IL80643A0 (en) | Controlled release pharmaceutical compositions | |
| ZA869255B (en) | Resinate sustained release dextromethorphan composition | |
| IL79903A0 (en) | Disc-like sustained release formulation | |
| GB8612781D0 (en) | Formulation | |
| GB8612780D0 (en) | Formulation | |
| ZA866218B (en) | Injectable sustained release formulation | |
| PH23476A (en) | Injectable semi-solid formulations | |
| GB2176999B (en) | Sustained release medicament | |
| GB8727590D0 (en) | Formulation | |
| GB8712251D0 (en) | Formulation | |
| GB8513358D0 (en) | Formulation | |
| GB8607864D0 (en) | Jack bolt | |
| IE862241L (en) | Injectable sustained release formulation | |
| GB8529500D0 (en) | Formulation | |
| GB8825541D0 (en) | Formulation | |
| ZA859645B (en) | Theophylline sustained release formulation | |
| IE851357L (en) | Sustained release composition | |
| EG17797A (en) | Controlled release formulation | |
| IE860577L (en) | Sustained release composition | |
| GB8506703D0 (en) | Formulation | |
| GB8521704D0 (en) | Formulation | |
| GB8521705D0 (en) | Formulation | |
| GB8524812D0 (en) | Formulation | |
| GB8500591D0 (en) | Formulation |